Metrochem API
India 3 duplicate records merged Updated 9 July 2026
Metrochem API is an API manufacturer based in India. It holds 23 valid CEPs across a filed portfolio of 19 molecules. Its filings concentrate with MINSA (CR) and CDSCO (India). Customs aggregates show $44.6M of exports covering 1,433 molecules to 61 destinations in 2025.
6
filings
across 2 regulators
Registered plants
| Site | FDA FEI |
| Hyderabad, India | Not on file |
What they file, and where
| Molecule | Regulators | Docs |
| Esomeprazole | EDQM | 3 |
| Omeprazole | EDQM | 3 |
| Rabeprazole Sodium Hydrate | EDQM | 2 |
| Antazoline | EDQM | 1 |
| Clopidogrel | EDQM | 1 |
| Copper Sulfate Pentahydrate | EDQM | 1 |
| Dabigatran Etexilate Mesilate | EDQM | 1 |
| Dapagliflozin Propylene Glycol Monohydrate | EDQM | 1 |
| Dimetindene | EDQM | 1 |
| Lacosamide | EDQM | 1 |
Show all 19 molecules on file
Also appears on these molecule pages
Show 10 more molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| MINSA (CR) | 4 | None |
| CDSCO (India) | 2 | None |
Scale
| Year | Revenue | Exports | Destinations |
| 2026 YTD | Not reported | $6.3M | 39 |
| 2025 | Not reported | $44.6M | 61 |
| 2024 | Not reported | $40.2M | 61 |
| 2023 | Not reported | $55.6M | 60 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Comparing suppliers?
Choose your molecules and target markets. Metrochem API comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- Customs aggregates
- Export values, molecule and destination counts